Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- About
Tradr 2X Long QBTS Daily ETF (QBTX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/10/2025: QBTX (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Analysis of Past Performance
Type ETF | Historic Profit 25.23% | Avg. Invested days 15 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  3.0 | ETF Returns Performance  4.0 |
| Profits based on simulation | Last Close 10/10/2025 |
Key Highlights
Volume (30-day avg) - | Beta - | 52 Weeks Range 19.66 - 135.94 | Updated Date - |
52 Weeks Range 19.66 - 135.94 | Updated Date - |
Upturn AI SWOT
Tradr 2X Long QBTS Daily ETF
ETF Overview
Overview
The Tradr 2X Long QBTS Daily ETF aims to provide daily investment results, before fees and expenses, of 200% (2x) the daily performance of the QBTS Index. It offers leveraged exposure to the biotechnology sector.
Reputation and Reliability
Information on the issuer's reputation and reliability is not readily available.
Management Expertise
Information on the management team's expertise is not readily available.
Investment Objective
Goal
To seek daily investment results, before fees and expenses, that correspond to 200% of the daily performance of the QBTS Index.
Investment Approach and Strategy
Strategy: The ETF employs a leveraged strategy, aiming to amplify the daily returns of the QBTS Index. It does not aim for long-term gains but rather short-term exposure.
Composition The ETF primarily holds financial instruments that provide leveraged exposure to the QBTS Index, which tracks the performance of a basket of publicly traded companies engaged in the biotechnology industry.
Market Position
Market Share: Data on the exact market share of the Tradr 2X Long QBTS Daily ETF in its specific sector is not easily accessible.
Total Net Assets (AUM): Information is not publicly available.
Competitors
Key Competitors
- LABU
- FAS
- TECL
Competitive Landscape
The ETF operates in a competitive landscape of leveraged ETFs, offering different levels of exposure to various sectors. This ETF has the advantage of providing 2x leverage to biotech, but is disadvantaged against competitor ETFs with high trading volumes.
Financial Performance
Historical Performance: Historical performance data is essential but not fully provided here, but high leverage will result in high volatility.
Benchmark Comparison: The ETF's performance should be compared to the QBTS Index to assess the effectiveness of its tracking and leverage.
Expense Ratio: Information is not publicly available.
Liquidity
Average Trading Volume
Assessment of the ETFu2019s liquidity based on its average trading volume can vary by data source.
Bid-Ask Spread
The bid-ask spread should be monitored to gauge the cost of trading the ETF, a wider spread indicates lower liquidity.
Market Dynamics
Market Environment Factors
Economic indicators, sector-specific growth prospects in the biotechnology industry, and overall market sentiment significantly influence the ETF's performance.
Growth Trajectory
The ETF's growth trajectory depends on the biotech sector's performance and the effectiveness of its leveraged strategy.
Moat and Competitive Advantages
Competitive Edge
The Tradr 2X Long QBTS Daily ETF's main advantage is providing 2x leveraged exposure to the biotech sector. The ETF's success is tied to the biotechnology sector's positive performance and the ETF's ability to accurately track the QBTS index. A key advantage lies in its ability to amplify short-term gains. However, the leveraged nature magnifies both gains and losses, making it a high-risk investment. Investors must be aware that the ETF is designed for short-term investment horizons due to the compounding effect of daily resets.
Risk Analysis
Volatility
The ETF's leveraged nature results in high volatility, which can lead to significant gains and losses.
Market Risk
Specific risks associated with the ETF include market risk related to biotech sector downturns and the risks associated with leveraged investments, like compounding and volatility.
Investor Profile
Ideal Investor Profile
The ideal investor is an experienced trader with a high-risk tolerance who understands the complexities of leveraged ETFs and is looking for short-term, aggressive exposure to the biotechnology sector.
Market Risk
The ETF is suitable for active traders seeking short-term gains, but not for long-term investors due to its leveraged nature and daily reset.
Summary
The Tradr 2X Long QBTS Daily ETF offers leveraged exposure to the biotechnology sector, seeking to amplify daily returns. It is designed for experienced traders with a high-risk tolerance and a short-term investment horizon. The ETF's performance is closely tied to the biotech sector's performance and its ability to accurately track the QBTS Index. Investors should be aware of the risks associated with leveraged investments, including high volatility and the compounding effect of daily resets. Due to limited data, specific investment strategies and AUM sizes cannot be determined.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC Filings
- ETF.com
- Bloomberg
- Issuer Website (if available)
Disclaimers:
The data provided is for informational purposes only and should not be considered financial advice. Investment decisions should be based on thorough research and consultation with a qualified financial advisor. Market share data may not be available or precise. Actual performance can vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Tradr 2X Long QBTS Daily ETF
Exchange NASDAQ | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website | ||
Under normal market circumstances, the fund will maintain at least 80% exposure to financial instruments that provide two times leveraged exposure to the daily performance of QBTS. The fund will enter into one or more swap agreements with major global financial institutions whereby the fund and the global financial institution will agree to exchange the return (or differentials in rates of return) earned or realized on QBTS. The fund is non-diversified.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.